Amy Trainor, Vice President and Project Director
Dr. Trainor has extensive experience in global pharmaceutical drug discovery and development. She has leadership expertise in overall drug development strategy and execution, discovery with an emphasis on medicinal chemistry, and development of global external partnerships.
Dr. Trainor joins Z53 Therapeutics after 30 years at AstraZeneca Pharmaceuticals. She is an inventor on 20 issued US patents.
George Trainor, Chief Discovery Consultant
Dr. George Trainor brings over 30 years of experience in the Biotechnology and Pharmaceutical industries. He has expertise in drug discovery strategy and execution, medicinal chemistry, and the application of transformative technologies.
Dr. Trainor completed his PhD at Harvard University, and was an NIH Postdoctoral Fellow at Columbia University.
Juliana Woda, Project Manager
Dr. Juliana M. Woda has extensive experience in biological research and drug development. Prior to Z53 Therapeutics, she worked as Director of Translational Research for Juventas Therapeutics in Cleveland, overseeing all aspects of preclinical development of novel biologics.
Juliana completed her PhD in Biological and Biomedical Sciences at Harvard University, specializing in Cell and Developmental Biology.